Dana-Farber Cancer Institute Reimbursement & Financial Overview
Dana-Farber Cancer Institute is a nonprofit, short-term acute care hospital in Boston, Massachusetts, providing inpatient and outpatient care focused on oncology, hematology, bone marrow transplantation, and specialized surgical oncology services. As a world-renowned cancer center serving the Greater Boston region and referral patients nationally and internationally, it offers patients access to comprehensive clinical services, clinical trials, multidisciplinary specialty programs, and the resources of a leading academic cancer institute.
Customize your policy alerts
Sign up for Dana-Farber Cancer Institute Reimbursement & Financial Overview policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
CMS Facility Identification & Reporting Details
CMS facility data for Dana-Farber Cancer Institute includes hospital classification, ownership, location, CMS Certification Number (CCN), and Medicare cost reporting period.
| Metric | Value |
|---|---|
| Address | 450 Brookline Ave, Boston, MA 02215 |
| County | Suffolk |
| CBSA | 14454 |
| Rural / Urban | U |
| CMS Certification Number (CCN) | 220162 |
| Facility Type | Short-Term Acute Care Hospital |
| Ownership | Non-Profit |
| Fiscal Year | Oct 2022 – Sep 2023 |
Dana-Farber Cancer Institute Financial Performance & Hospital Financial Data
Dana-Farber Cancer Institute’s financial performance provides insight into the hospital’s financial stability, operating efficiency, cost pressures, and capacity to sustain patient care and invest in future growth. These metrics help finance, revenue cycle, and managed care teams evaluate performance, identify financial trends, and better understand the hospital’s overall financial position.
Select: Balance Sheet1 / 4
| Account | Amount |
|---|---|
| Total Current Assets | $710M |
| Total Assets | $4.7B |
| Total Current Liabilities | $470M |
| Total Liabilities | $1.4B |
| Total Equity (Fund Balance) | $3.4B |
| Current Ratio | 1.5 |
| Debt-to-Equity | 0.41 |
Dana-Farber Cancer Institute Medicare, Medicaid & Payer Mix
Dana-Farber Cancer Institute’s Medicare, Medicaid, payer mix, and community benefit data provide insight into reimbursement exposure, patient coverage trends, uncompensated care, and reliance on government and commercial payers. These metrics help assess payer composition, reimbursement dynamics, financial risk, and the hospital’s overall revenue profile.
Select: Community Benefit1 / 4
| Metric | Value |
|---|---|
| Charity Care Cost | — |
| Bad Debt Expense | — |
| Uncompensated Care Cost | — |
| Total Unreimbursed & Uncompensated | — |
Dana-Farber Cancer Institute Taxonomy
Explore new and updated payer policies relevant to Dana-Farber Cancer Institute. Track policy changes that may affect coverage, billing requirements, reimbursement, and revenue cycle operations.
| Code | Type |
|---|---|
| 282N00000X [PRIMARY] | General Acute Care Hospital |
Dana-Farber Cancer Institute NPI Registration & Network
Explore NPI affiliations associated with Dana-Farber Cancer Institute, including connected healthcare organizations, individual practitioners, specialties, and provider network relationships. A National Provider Identifier (NPI) is a unique 10-digit ID assigned by CMS to healthcare providers. Type 1 NPIs identify individual practitioners, while Type 2 NPIs identify organizations such as hospitals, clinics, and group practices.
Registration Details
NPI registration data for Dana-Farber Cancer Institute includes the hospital’s National Provider Identifier, registered business name, mailing address, authorized official, and registration date.
| Metric | Value |
|---|---|
| NPI | 1851333686 |
| Doing Business As | Dana-Farber Cancer Institute |
| Mailing Address | Po Box 414744, Boston, MA 02241-4744 |
| Phone | (617) 632-3000 |
| Authorized Official | PAUL DEMBINSKI, SR. DIRECTOR OF PFS |
| Authorized Official Phone | (617) 632-3935 |
| NPI Registered Since | Jun 13, 2006 |
NPI Network
Organizations and individual practitioners affiliated with Dana-Farber Cancer Institute's Tax Identification Number (TIN), as registered in the NPPES database.
4 rows
| NPI Type 2 | Organization | City | State |
|---|---|---|---|
| 1225079940 | DANA-FARBER CANCER INSTITUTE, INC. | BOSTON | MA |
| 1699954842 | DANA FARBER CANCER INSTITUTE | BOSTON | MA |
| 1346433257 | DANA-FARBER CANCER INSTITUTE, INC. | BOSTON | MA |
| 1215097910 | DANA FARBER CANCER INSTITUTE | BOSTON | MA |
| Type 1 NPIs | States Spanned |
|---|---|
| 1132 | 26 |
Also Known As
Alternate names registered for this facility's NPI in the NPPES registry — trade names (doing business as), former legal names, and other names.
| Name | Type |
|---|---|
| Dana-Farber Cancer Institute | Doing Business As |
Frequently Asked Questions
References
- 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
- 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
- 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.